Cargando…

A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer

Detalles Bibliográficos
Autores principales: Okuno, Keisuke, Kandimalla, Raju, Mendiola, Marta, Balaguer, Francesc, Bujanda, Luis, Fernandez-Martos, Carlos, Aparicio, Jorge, Feliu, Jaime, Tokunaga, Masanori, Kinugasa, Yusuke, Maurel, Joan, Goel, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854096/
https://www.ncbi.nlm.nih.gov/pubmed/36670412
http://dx.doi.org/10.1186/s12943-022-01699-2
_version_ 1784873043061899264
author Okuno, Keisuke
Kandimalla, Raju
Mendiola, Marta
Balaguer, Francesc
Bujanda, Luis
Fernandez-Martos, Carlos
Aparicio, Jorge
Feliu, Jaime
Tokunaga, Masanori
Kinugasa, Yusuke
Maurel, Joan
Goel, Ajay
author_facet Okuno, Keisuke
Kandimalla, Raju
Mendiola, Marta
Balaguer, Francesc
Bujanda, Luis
Fernandez-Martos, Carlos
Aparicio, Jorge
Feliu, Jaime
Tokunaga, Masanori
Kinugasa, Yusuke
Maurel, Joan
Goel, Ajay
author_sort Okuno, Keisuke
collection PubMed
description
format Online
Article
Text
id pubmed-9854096
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98540962023-01-21 A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer Okuno, Keisuke Kandimalla, Raju Mendiola, Marta Balaguer, Francesc Bujanda, Luis Fernandez-Martos, Carlos Aparicio, Jorge Feliu, Jaime Tokunaga, Masanori Kinugasa, Yusuke Maurel, Joan Goel, Ajay Mol Cancer Correspondence BioMed Central 2023-01-20 /pmc/articles/PMC9854096/ /pubmed/36670412 http://dx.doi.org/10.1186/s12943-022-01699-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Okuno, Keisuke
Kandimalla, Raju
Mendiola, Marta
Balaguer, Francesc
Bujanda, Luis
Fernandez-Martos, Carlos
Aparicio, Jorge
Feliu, Jaime
Tokunaga, Masanori
Kinugasa, Yusuke
Maurel, Joan
Goel, Ajay
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
title A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
title_full A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
title_fullStr A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
title_full_unstemmed A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
title_short A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
title_sort microrna signature for risk-stratification and response prediction to folfox-based adjuvant therapy in stage ii and iii colorectal cancer
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854096/
https://www.ncbi.nlm.nih.gov/pubmed/36670412
http://dx.doi.org/10.1186/s12943-022-01699-2
work_keys_str_mv AT okunokeisuke amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT kandimallaraju amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT mendiolamarta amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT balaguerfrancesc amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT bujandaluis amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT fernandezmartoscarlos amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT apariciojorge amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT feliujaime amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT tokunagamasanori amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT kinugasayusuke amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT maureljoan amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT goelajay amicrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT okunokeisuke micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT kandimallaraju micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT mendiolamarta micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT balaguerfrancesc micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT bujandaluis micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT fernandezmartoscarlos micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT apariciojorge micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT feliujaime micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT tokunagamasanori micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT kinugasayusuke micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT maureljoan micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer
AT goelajay micrornasignatureforriskstratificationandresponsepredictiontofolfoxbasedadjuvanttherapyinstageiiandiiicolorectalcancer